Correlation Between 06406RBM8 and Abcellera Biologics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both 06406RBM8 and Abcellera Biologics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining 06406RBM8 and Abcellera Biologics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between BK 5834 25 OCT 33 and Abcellera Biologics, you can compare the effects of market volatilities on 06406RBM8 and Abcellera Biologics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in 06406RBM8 with a short position of Abcellera Biologics. Check out your portfolio center. Please also check ongoing floating volatility patterns of 06406RBM8 and Abcellera Biologics.

Diversification Opportunities for 06406RBM8 and Abcellera Biologics

-0.2
  Correlation Coefficient

Good diversification

The 3 months correlation between 06406RBM8 and Abcellera is -0.2. Overlapping area represents the amount of risk that can be diversified away by holding BK 5834 25 OCT 33 and Abcellera Biologics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Abcellera Biologics and 06406RBM8 is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BK 5834 25 OCT 33 are associated (or correlated) with Abcellera Biologics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Abcellera Biologics has no effect on the direction of 06406RBM8 i.e., 06406RBM8 and Abcellera Biologics go up and down completely randomly.

Pair Corralation between 06406RBM8 and Abcellera Biologics

Assuming the 90 days trading horizon BK 5834 25 OCT 33 is expected to generate 0.09 times more return on investment than Abcellera Biologics. However, BK 5834 25 OCT 33 is 10.71 times less risky than Abcellera Biologics. It trades about 0.12 of its potential returns per unit of risk. Abcellera Biologics is currently generating about -0.13 per unit of risk. If you would invest  10,394  in BK 5834 25 OCT 33 on November 27, 2024 and sell it today you would earn a total of  92.00  from holding BK 5834 25 OCT 33 or generate 0.89% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy95.24%
ValuesDaily Returns

BK 5834 25 OCT 33  vs.  Abcellera Biologics

 Performance 
       Timeline  
BK 5834 25 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days BK 5834 25 OCT 33 has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, 06406RBM8 is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.
Abcellera Biologics 

Risk-Adjusted Performance

Insignificant

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Abcellera Biologics are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite quite persistent fundamental indicators, Abcellera Biologics is not utilizing all of its potentials. The current stock price mess, may contribute to short-term losses for the institutional investors.

06406RBM8 and Abcellera Biologics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with 06406RBM8 and Abcellera Biologics

The main advantage of trading using opposite 06406RBM8 and Abcellera Biologics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if 06406RBM8 position performs unexpectedly, Abcellera Biologics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Abcellera Biologics will offset losses from the drop in Abcellera Biologics' long position.
The idea behind BK 5834 25 OCT 33 and Abcellera Biologics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..

Other Complementary Tools

Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules